Beyond Air New US Patent App #20260284331 Published Today For "METHODS EMPLOYING GASEOUS NITRIC OXIDE FOR INHIBITING TUMOR GROWTH".

9/24/2026
Impact: 75
Healthcare

Beyond Air has published a new US patent application (US Patent App #20260284331) for a method utilizing gaseous nitric oxide to inhibit tumor growth. This development could have significant implications for cancer treatment strategies. The stock ticker for Beyond Air is XAIR.

AI summary, not financial advice

Share: